Breakthrough treatment for hurting horses

Jun 30, 2011
Osteoarthritis is a common problem in racing and other performance horses.

A new osteoarthritis drug combination trialled by University of Sydney researchers could significantly extend the working life of racing and other performance horses and could potentially benefit humans.

Various medications have been assessed for the treatment of in horses, but this is one of the first studies to show a new drug combination has the ability to slow down damage to joints, rather than just alleviate pain.

"Osteoarthritis is a major cause of wastage in athletic horses, with a significant economic impact on the equine industry," said Dr. Toby Koenig, surgery resident at the University of Sydney Veterinary Teaching Hospital, Camden.

Dr. Koenig led the clinical research trial at the hospital's Research and Clinical Training Unit (REaCT) which involved treating osteoarthritis in 16 horses undergoing simulated race training.

"We found a new combination of three commonly used drugs - pentosan polysulphate, and - can reduce the damage experienced during ," said Dr. Koenig, who will present his results at a conference on the Gold Coast this Friday 1 July.

"Until now the focus has been on minimising pain for horses suffering from osteoarthritis. We think this new could have significant impact on the way horses are treated, potentially extending careers of horses in racing, dressage and other competitive events."

Professor Andrew Dart, the Director of REaCT and one of Dr. Koenig's supervisors, said the study is a significant international and multi-institutional investigation, with major implications not just for horses, but for other species.

This study has brought together some of the world's leading researchers into equine osteoarthritis, here and in the United States, to produce a significant research outcome which will impact on the welfare of and potentially more widely."

The co-supervisor of the project is Professor Leo Jeffcott, former Dean of the University of Sydney's Faculty of Veterinary Science and official equestrian veterinarian at the previous five Olympics.

Associate Professor Chris Little, Director of the Raymond Purves Bone and Joint Research Laboratory at Sydney's Royal North Shore Hospital, worked with the investigators to analyse the combination's impact on the horses' joints.

The Australian team also collaborated with Professor Wayne McIlwraith, Director of the Orthopaedic Research Centre at Colorado State University and regarded as the preeminent expert in equine joint disease and surgery.

The research will also be presented at the American College of Veterinary Surgery's symposium in Chicago later this year.

Explore further: Sheepdogs use just two simple rules to round up large herds of sheep

Provided by University of Sydney

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Humans aren't the only ones with obesity problems

Apr 24, 2007

Horses are inheritably couch potatoes. An overeating, slothful horse leads to an obese horse. Unlike humans, however, horse owners often don’t see the dangers of an obese horse. Caretakers may see no harm ...

Stem cell research to benefit horse owners and trainers

Oct 21, 2008

In a potential breakthrough for the performance horse industry (such as racing and polo), Melbourne scientists are aiming to harness stem cells to repair tendon, ligament, cartilage and bone damage in horses.

Special horseshoes measure acceleration in horses

Jul 07, 2008

The most frequent injuries that horses suffer are derived from pressure exerted by riders, and knowing which forces are involved when horses move can prove highly informative when considering treatment for such injuries.

Recommended for you

Wolves susceptible to yawn contagion

4 hours ago

Wolves may be susceptible to yawn contagion, according to a study published August 27, 2014 in the open-access journal PLOS ONE by Teresa Romero from The University of Tokyo, Japan, and colleagues.

User comments : 0